Immunome

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Immunome 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About IMNM

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. 

CEO
Clay B. Siegall
CEOClay B. Siegall
Employees
177
Employees177
Headquarters
Bothell, Washington
HeadquartersBothell, Washington
Founded
2006
Founded2006
Employees
177
Employees177

IMNM Key Statistics

Market cap
2.37B
Market cap2.37B
Price-Earnings ratio
-8.63
Price-Earnings ratio-8.63
Dividend yield
Dividend yield
Average volume
1.09M
Average volume1.09M
High today
$22.70
High today$22.70
Low today
$20.66
Low today$20.66
Open price
$21.81
Open price$21.81
Volume
2.24M
Volume2.24M
52 Week high
$27.65
52 Week high$27.65
52 Week low
$5.15
52 Week low$5.15

Stock Snapshot

With a market cap of 2.37B, Immunome(IMNM) trades at $20.91. The stock has a price-to-earnings ratio of -8.63.

On 2026-03-05, Immunome(IMNM) stock moved within a range of $20.66 to $22.70. With shares now at $20.91, the stock is trading +1.2% above its intraday low and -7.9% below the session's peak.

Trading activity shows a volume of 2.24M, compared to an average daily volume of 1.09M.

The stock's 52-week range extends from a low of $5.15 to a high of $27.65.

The stock's 52-week range extends from a low of $5.15 to a high of $27.65.

Analyst ratings

100%

of 14 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own IMNM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.